GPT and metabolic dysfunction-associated steatotic liver disease: Most non-invasive tests for the diagnosis of NAFLD include AST/ALT levels [32]; however, Verma et al. reported that the AUCs for ALT levels correlating with NASH and advanced fibrosis were 0.62 and 0.46, respectively [38].